Screener

Eligibility screening

Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Ad…

Sponsored by Medical University of South CarolinaStudy detailsClinicalTrials.gov

1 US site in SC

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.